Issie Kirby
Stock Analyst at Redburn Atlantic
(0.61)
# 2,971
Out of 4,479 analysts
5
Total ratings
33.33%
Success rate
-7.01%
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DXCM DexCom | Initiates: Neutral | $130 | $112.49 | +15.57% | 1 | May 30, 2024 | |
| TNDM Tandem Diabetes Care | Initiates: Buy | $60 | $39.15 | +53.26% | 1 | May 30, 2024 | |
| PODD Insulet | Initiates: Buy | $235 | $197.19 | +19.17% | 1 | May 30, 2024 | |
| COO The Cooper Companies | Upgrades: Buy | $125 | $86.51 | +44.49% | 2 | Mar 19, 2024 |
DexCom
May 30, 2024
Initiates: Neutral
Price Target: $130
Current: $112.49
Upside: +15.57%
Tandem Diabetes Care
May 30, 2024
Initiates: Buy
Price Target: $60
Current: $39.15
Upside: +53.26%
Insulet
May 30, 2024
Initiates: Buy
Price Target: $235
Current: $197.19
Upside: +19.17%
The Cooper Companies
Mar 19, 2024
Upgrades: Buy
Price Target: $125
Current: $86.51
Upside: +44.49%